Mitochondrial Thiols in the Regulation of Cell Death Pathways

Abstract

Significance: Regulation of mitochondrial H₂O₂ homeostasis and its involvement in the regulation of redox-sensitive signaling and transcriptional pathways is the consequence of the concerted activities of the mitochondrial energy- and redox systems. Recent Advances: The energy component of this mitochondrial energy-redox axis entails the formation of reducing equivalents and their flow through the respiratory chain with the consequent electron leak to generate \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}$${ \rm O}_2^{ \cdot - }$$ \end{document} and H₂O₂. The mitochondrial redox component entails the thiol-based antioxidant system, largely accounted for by glutathione- and thioredoxin-based systems that support the activities of glutathione peroxidases, peroxiredoxins, and methionine sulfoxide reductase. The ultimate reductant for these systems is NADPH: mitochondrial sources of NADPH are the nicotinamide nucleotide transhydrogenase, isocitrate dehydrogenase-2, and malic enzyme. NADPH also supports the glutaredoxin activity that regulates the extent of S-glutathionylation of mitochondrial proteins in response to altered redox status. Critical Issues: The integrated network of these mitochondrial thiols constitute a regulatory device involved in the maintenance of steady-state levels of H₂O₂, mitochondrial and cellular redox and metabolic homeostasis, as well as the modulation of cytosolic redox-sensitive signaling; disturbances of this regulatory device affects transcription, growth, and ultimately influences cell survival/death. Future Directions: The modulation of key mitochondrial thiol proteins, which participate in redox signaling, maintenance of the bioenergetic machinery, oxidative stress responses, and cell death programming, provides a pivotal direction in developing new therapies towards the prevention and treatment of several diseases. Antioxid. Redox Signal. 17, 1714–1727.

Introduction

M itochondria meet the cell's energy demands that support metabolic, osmotic, and mechanical functions; they are sources of H₂O₂, and play a pivotal role as mediators of the intrinsic apoptotic pathway. Organs that demand significantly larger amounts of energy, such as the central nervous system, are particularly susceptible to an energy crisis and concomitant cell death. Mitochondria integrate distinct cytosolic signaling pathways and (a) generate second messengers, such as H₂O₂, implicated in the modulation of redox-sensitive signaling pathways, (b) are involved in the regulation of NAD⁺/NADH homeostasis, influencing the activation of the cofactor PGC1α via sirtuins, and (c) are the cell's generators of ATP that supports the cell's energy demands (Fig. 1). The generation of H₂O₂ reports the mitochondrial energy charge to cytosol (176) and is implicated in the regulation of the cell's redox status, thus transducing redox signals into a wide variety of responses, such as proliferation, differentiation, and cellular death pathways (119). Cells with high metabolic rate are exposed to large quantities of oxidants, which renders them more vulnerable to oxidative stress-induced cell death (2); thus, high levels of oxidants disrupt redox signaling and mediate detrimental effects inherent in mitochondrial dysfunction in a variety of pathologies including neurodegenerative disorders (13, 14, 162), diabetes (85, 107), cardiovascular disease (159), and aging (112, 126, 177). Hence, oxidants such as H₂O₂ have a dual function: on the one hand, H₂O₂ is involved in the fine tuning of signaling and transcription through modulation of redox-sensitive pathways; on the other hand, higher levels of H₂O₂, as expected with a diminished energy-conservation capacity of mitochondria, are involved in oxidative damage to cell constituents, a well-documented phenomenon under the term oxidative stress.

FIG. 1.

The mitochondrial energy–redox axis and generation of redox- and energy messengers. Mitochondria maintain a fine tuning of NAD⁺/NADH ratios, generate H₂O₂ involved in the regulation of redox-sensitive signaling and transcriptional pathways, and ATP to meet the energy demands of the cell. The regulation of redox-sensitive signaling is exemplified with the 2-electron pathway (Equations 4 and 8 in the text). Activation of PGC1α is given as an example of regulation by NAD⁺/NADH ratios and of interaction with the energy demands/energy sensors panel. There is also interaction between the latter panel and the regulation of redox-sensitive signaling by H₂O₂, for its generation reports the mitochondrial energy charge to cytosol (176) and is implicated in the regulation of the cell's redox status. oA-ADPr, 2’-o-acetyl-ADP-ribose; Ac, acetyl moiety; Nic, nicotinamide.

Cell death occurs mainly by apoptosis and necrosis, pathways that differ functionally and mechanistically. The critical role of mitochondria in the intrinsic apoptotic pathway is well documented (89, 172, 184) and entails changes in respiratory capacity and mitochondrial membrane potential, as well as increased mitochondrial permeability transition (95). Necrosis, on the other hand, is usually triggered by infection, trauma, or toxins (114), and is associated with major ultrastructural abnormalities of mitochondria (95). Generally, apoptosis may occur with low or moderate, but lethal oxidative stimuli, whereas necrosis would result from severe oxidative challenges that overcome the cellular antioxidant defenses and energy-transducing pathways (100). The intracellular ATP levels constitute a critical signal directing the cells towards either type of cell death (203), because apoptosis requires energy in the form of ATP to assemble the apoptotic machinery (104, 151), which is dissipated during necrosis due to depletion of energy stores and damage of energy-transducing capacity in mitochondria.

Mitochondrial thiols that maintain redox reactions mainly include GSH and thioredoxin-2 (Trx2) and the associated enzymes—glutathione reductase (GR) and thioredoxin reductase (TrxR)—supporting the activities of glutathione peroxidase, glutaredoxin-2 (Grx2), and peroxiredoxin-3 (Prx3) and −5 (Prx5) (34, 70, 148). These mitochondrial thiols have been shown to influence the cellular death pathway (49, 175). Under physiological conditions, the mitochondrial thiol-based antioxidant systems maintain steady-state levels of H₂O₂ and an adequate cell's redox status, thereby preventing cell death by the pathways mentioned above. Hence, the mitochondrial thiol state is a critical mediator of metabolic-, signaling-, and cell death-related processes. Thiol groups in proteins play an important role in redox signaling by shuffling between oxidized and reduced states (41).

The Mitochondrial GSH Pool and Redox Status

GSH, synthesized by two ATP-dependent steps involving γ glutamylcysteine synthetase and GSH synthase (128), is found in two major pools in cytosol and mitochondria: the latter is the most abundant thiol in mitochondria and acts as a cofactor for glutathione peroxidase, glutathione-S-transferases, and sulfiredoxins (110, 150). Cellular viability and redox status are controlled in part by GSH (45), which plays a dual role by participating in the reduction of peroxides and acting as an nucleophile upon conversion of electrophilic centers to thioether bonds (147). GSH is imported from the cytosol via transporters in the outer and inner mitochondrial membranes (54): dicarboxylate- and 2-oxoglutarate carriers in the inner mitochondrial membrane were identified first in kidney (25, 26, 97, 113) and then in liver (204). The involvement of GSH in redox pathways results in GSSG formation. However, at variance with cytosolic GSSG, mitochondrial GSSG cannot be exported, thus increasing mitochondria susceptibility to protein thiol oxidation and increasing the significance of systems involved in the interconversion between GSH and GSSG to maintain the redox status and provide an environment appropriate for disulfide bond formation during folding of nascent proteins (71).

The mitochondrial GSH:GSSG ratio is greater than 100:1 and is widely used as an indicator of the redox status, calculated by the Nernst equation (E _hc=E ₀+30 log ([GSSG]/GSH]²) (80). The redox potential of mitochondrial GSH/GSSG couple was calculated as approximately −300 mV and that of the Trx2_reduced/Trx2_oxidized couple as −340 mV (87). Although these redox couples are maintained independently in nonequilibrium steady state across different subcellular compartments, these values indicate a more reducing environment in mitochondria than in cytosol (−280 mV for Trx1 and −260 to −200 mV for GSH/GSSG) and in endoplasmic reticulum (−185 mV for GSH/GSSG) (58, 82).

The mitochondrial redox status cannot be viewed independent of its energy-transducing capacity but integrated in a mitochondrial energy–redox axis (Fig. 2). The energy component of this axis is encompassed by the generation of reducing equivalents (NADH and FP₂H₂) by the tricarboxylic acid cycle (TCA) and their flow through the respiratory chain with concomitant generation of \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}$${ \rm O}_2^{ \cdot - }$$ \end{document} and H₂O₂. The redox component is the domain of H₂O₂ removal systems—mainly glutathione peroxidase and Prx3—that use GSH and Trx2 as electron donors. The ultimate reductant of these systems is NADPH (supporting the activities of glutathione reductase and thioredoxin reductase). Hence, the steady-state levels of mitochondrion-generated H₂O₂ in cytosol (and its involvement in domain-specific signaling) are largely determined by maintenance of the mitochondrial energy-redox axis and are strictly dependent on the mitochondrial GSH pool and associated enzymes (161). Mitochondrial NADPH is mainly formed through three pathways: NADP⁺-dependent isocitrate dehydrogenase (IDH₂), malic enzyme, and nicotinamide nucleotide transhydrogenase (NNT). Of these pathways, 50% of the mitochondrial NADPH pool is uncoupler sensitive, thus suggesting that the NNT-catalyzed reduction of NADP⁺ accounts for more than 50% of the mitochondrial NADPH pool (154). NNT—a nuclear encoded mitochondrial 110 kDa protein located on the inner mitochondrial membrane (64)—catalyzes the reversible reduction of NADP⁺ to NADPH and the conversion of NADH to NAD⁺ (Equation 1). \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document} \begin{align*}{\rm NADH} + { \rm NADP}^ + + { \rm H}^ + _{ {\rm intermembrane}} \, \leftrightarrows \,{ \rm NAD}^ + + { \rm NADPH}+ { \rm H}^ + _{ \rm matrix} \qquad\qquad\qquad {\rm [Eq. \ 1]}\end{align*} \end{document}

FIG. 2.

Role of the mitochondrial energy–redox axis in maintenance of cellular H₂O₂ levels. Reducing equivalents from the tricarboxylic acid cycle flow through the respiratory chain (RC); electron leak accounts for 2%–3% of O₂ consumed in the form of \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}$${ \rm O}_2^{ \cdot - }$$ \end{document} and H₂O₂. Reduction of H₂O₂ is supported by thiol-based systems, for which the ultimate reductant is NADPH. Sources of mitochondrial NADPH: nicotinamide nucleotide transhydrogenase (NNT), isocitrate dehydrogenase-2 (IDH₂), and malic enzyme. Domain-specific signaling entailing regulation of redox-sensitive JNK- and insulin/IGF1 signaling (IIS) pathways,

The proton gradient across the mitochondrial inner membrane strongly stimulates the forward reaction (Fig. 3), [i.e., the generation of NADPH and the subsequent H₂O₂ reduction (197)]. NNT plays an important role in regulating cellular redox homeostasis, energy metabolism, and apoptotic pathways (196). Knockdown of NNT in PC12 cells results in an altered redox status encompassed by decreased cellular NADPH levels and GSH/GSSG ratios and increased H₂O₂ levels, as well as an impaired mitochondrial energy-transducing capacity. The activation of redox-sensitive signaling (JNK) by H₂O₂ after NNT suppression induces mitochondrion-dependent intrinsic apoptosis and results in decreased cell viability (196). The oxidized cellular redox state and decline in bioenergetics, as a consequence of NNT knockdown, cannot be viewed as independent events, but rather as interdependent relationships coordinated by the mitochondrial energy–redox axis. Disruption of electron flux from fuel substrates to redox components due to NNT suppression induces not only mitochondrial dysfunction but also cellular disorders or cell death through redox-sensitive signaling.

FIG. 3.

NNT-supported mitochondrial thiol-based antioxidant system. At high Δψ, the forward reaction catalyzed by NNT is favored (see Equation 1 in the text), thus supporting the generation of NADPH, the ultimate reductant for the GSH and thioredoxin-based mitochondrial antioxidant systems. GSH, via glutathione reductase, supports the glutathione peroxidase (GPx) system, whereas thioredoxin (Trx), via thioredoxin reductase, is a requirement for peroxiredoxin- and methionine sulfoxide reductase activities.

Mitochondrial Protein S-Glutathionylation

Mitochondrial generation of oxidants and free radicals is associated with reversible and irreversible modifications of target proteins (Fig. 4), mainly involving S-nitrosylation and S-glutathionylation of redox-sensitive cysteinyl residues (Fig. 5) and nitration of tyrosyl residues. The increased GSSG formation and the lack of export of GSSG from mitochondria renders these organelles more susceptible to oxidative conditions and S-glutathionylation reactions through thiol-disulfide exchange (Equation 2) that may be associated with impairment or protection of protein function. Protein mixed disulfides are also formed upon the reaction of GSH with S-nitrosylated proteins by a S-thiolation mechanism (Equation 3) and sulfenic acid intermediates (Equation 4). Protein mixed disulfides can be formed by one- or two-electron pathways: the former yields a protein thiyl radical (Equation 5) that upon conjugation with a thiol (e.g., GSH) forms a protein disulfide anion radical (Equation 6); the disulfide anion radical reduces O₂ to \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}$${ \rm O}_2^{ \cdot - }$$ \end{document} with formation of a protein disulfide (Equation 7). The 2-electron pathway yields a sulfenic acid derivative (Equation 8; e.g., upon reaction of the thiol with H₂O₂), which is converted into a protein disulfide upon nucleophilic addition by a thiol (Equation 4; e.g., GSH) (see also Fig.1). \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document} \begin{align*} \Pr - { \rm S}^ - + { \rm GSSG} \rightarrow \Pr - { \rm S} - { \rm SG} + { \rm GS}^ - \qquad\qquad\qquad { \rm [Equation \ 2]}\end{align*} \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document} \begin{align*} \Pr - { \rm S} - { \rm NO} + { \rm GS}^ - \rightarrow \Pr - { \rm S} - { \rm SG} + { \rm NO}^ - \qquad\qquad\qquad { \rm [Equation \ 3] }\end{align*} \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document} \begin{align*} \Pr - { \rm S} - { \rm OH} + { \rm GS}^ - \rightarrow \Pr - { \rm S} - { \rm SG} + { \rm HO}^ - \qquad\qquad\qquad { \rm [Equation \ 4] }\end{align*} \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document} \begin{align*} \Pr - { \rm S}^ - + { \rm R}^{ \cdot} \rightarrow \Pr {- S}^{ \cdot} + { \rm R}^ - \qquad\qquad\qquad { \rm [Equation \ 5] }\end{align*} \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document} \begin{align*} \Pr - { \rm S}^{ \cdot} + { \rm GS}^ - \rightarrow \Pr - { \rm S} {- SG}^{ \cdot^ - } \qquad\qquad\qquad{ \rm [Equation \ 6] }\end{align*} \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document} \begin{align*} \Pr - { \rm S} { - SG}^{ \cdot ^ - } + { \rm O}_2 \rightarrow \Pr - { \rm S} { - SG} + { \rm O}_2^{ \cdot ^- } \qquad\qquad\qquad { \rm [Equation \ 7]}\end{align*} \end{document} \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document} \begin{align*} \Pr - { \rm S}^ - + { \rm H}_2{ \rm O}_2 \rightarrow \Pr - \hbox{S - }{ \rm OH} + { \rm HO}^ - \qquad\qquad\qquad { \rm [Equation \ 8] }\end{align*} \end{document}

FIG. 4.

Mitochondrial generation of oxidants and their involvement in protein post-translational modifications. Univalent reduction of O₂, largely by reverse electron transfer (RET) in the respiratory chain, generates \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}$${ \rm O}_2^{ \cdot - }$$ \end{document} , which stoichiometrically disproportionates to H₂O₂. The 5-electron oxidation of the guanidine group of arginine by nitric oxide synthase (nNOS or eNOS) generates nitric oxide (^.NO). The reaction of ^.NO (from NOS activity) with \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}$${ \rm O}_2^{ \cdot - }$$ \end{document} (from mitochondrial RET) generates the oxidant peroxynitrite (ONOO⁻). These species are involved by different mechanisms in post-translational modifications of proteins.

FIG. 5.

Post-translational modifications entailing cysteinyl moieties of proteins. Disulfide linkage is reversed by glutaredoxins and thioredoxins. Oxidation to sulfenic acid by H₂O₂ and ONOO⁻; hyperoxidation of Pr-S-OH to sulfinic acid (Pr-SOOH) by H₂O₂; GSSG-mediated protein glutathionylation, reversed by glutaredoxins. The S-glutathionylated protein can also be formed by S-thiolation of Pr-S-NO and nucleophilic attack of GS– on Pr-S-OH. NOx, a species such as NO⁺ or GSNO or N₂O₃.

Regardless of the molecular mechanisms, S-glutathionylation is one of the most important protein post-translational modifications and is viewed as a regulatory device for proteins involved in energy metabolism, redox signaling, and apoptosis (40, 41, 63, 92, 116). In mitochondria, aconitase (57), α-ketoglutarate dehydrogenase (133), isocitrate dehydrogenase (90), succinyl-CoA transferase (51), and aldehyde dehydrogenase (185) can be inhibited upon glutathionylation. Electron transport chain complexes I (170), II (24), and V (51,186) are also sensitive to glutathionylation. S-glutathionylation of succinyl-CoA transferase and ATP synthase (F₁ complex, α-subunit) in brain mitochondria resulted in a decrease of activity and a substantially low reduction potential (−171 mV); supplementation of mitochondria with respiratory substrates to complex I or complex II increased NADH and NADPH levels, restored GSH levels through reduction of GSSG and deglutathionylation of mitochondrial proteins, and resulted in a more reducing mitochondrial environment (−291 mV) (51). Excessive protein glutathionylation upon treatment with diamide at high concentrations resulted in bioenergetics failure and cell death; however, low diamide concentrations lead to an apparently adaptive response [i.e., increased glycolytic flux and cell viability remained unchanged (63)]. Treatment of mitochondria from human dopaminergic neuroblastoma cells with neuromelanin increased GSH and free thiol levels by releasing GSH from glutathionylated mitochondrial complex I, thereby exposing critical thiols to detrimental oxidation and subsequent mitochondrial permeability transition and apoptosis (125). These results support the notion that reversible formation of mixed disulfides could serve as a mechanism that protects critical sulfhydryls in mitochondria from further oxidation (e.g., protein sulfinic and sulfonic acids) (62, 145).

The deglutathionylation of protein mixed disulfides is the domain of Grx (116) by a monothiol mechanism (67). The oxidized form of Grx is reduced by GSH, regenerated from GSSG by NADPH-supported glutathione reductase (GR). Cytosolic Grx1 is involved in multiple cellular processes (30, 68). Mitochondrial Grx2 (52) is about 1.5–3-fold more efficient than cytosolic Grx1 in protein de-glutathionylation (102) and is strongly implicated in mitochondrial redox control. Oxidized Grx1 is exclusively reduced by GSH, whereas oxidized Grx2 can also be a substrate for TrxR (79), which enables Grx2 catalysis in a wide range of GSH/GSSG values and conditions of oxidative stress (15).

The role of Grx2 function in the maintenance of the mitochondrial redox status gains further significance when considering that Grx2 knockdown led to increased sensitivity to cell death (103), whereas overexpression of Grx2 decreased the susceptibility of cells to oxidants and inhibited cytochrome c release and caspase activation (48); moreover, inhibition of Grx1 by cadmium did not sensitize to oxidative damage (103). The protein level of Grx2 is less than 1/20 of that of Grx1: this emphasizes the regulatory role of Grx2 upon specific mitochondrial protein targets rather than an antioxidant itself. The cytoprotective role of Grx2 may be related to the activation of Akt signaling and involves the redox-sensitive transcription factor NF-κB and anti-apoptotic Bcl-2 (123). Human Grx2 has been characterized as an iron–sulfur center-containing component of the thioredoxin family that may serve as a redox sensor that controls the activation of Grx2 during conditions of oxidative stress (68); this expands the interaction between oxidants, mitochondrial redox status, and protein glutathionylation. Grx1 activity in the mitochondrial intermembrane space (47, 137) is involved in the regulation of complex I and VDAC activity (88), mitochondrial membrane potential, and apoptosis, and implicated in neurodegenerative diseases (155).

Mitochondrial Thiols, H₂O₂, and Domain-Specific Signaling

Imbalanced H₂O₂ regulation can shift the cell from a reduced state to an oxidized state and further induce apoptosis and/or necrosis (6). Moreover, mitochondria provide a setting for relatively high \documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}$${ \rm O}_2^{ \cdot - }$$ \end{document} levels (compared with cytosol) and its reaction with ^.NO (mostly diffusing from cytosol, while the existence of mitochondrial NOS is still debatable (127, 142, 180)) generates ONOO⁻ at diffusion-controlled rates, an oxidant that may be associated with the initial steps of cell death pathways (136). Thus, maintenance of mitochondrial H₂O₂ homeostasis is critical for regulation of domain-specific redox-sensitive signaling pathways (171). This concept requires careful consideration of spatial regulation of H₂O₂ signals (178), its generation at specific cellular locations (82), occurrence of H₂O₂ gradients across distinct cellular compartments (5) and their regulated transfer by aquaporin (117), and the modulation of Prx activity close to the site of H₂O₂ generation (191).

Maintenance of mitochondrial H₂O₂ homeostasis is the domain of glutathione peroxidase and Prx: the latter are a family of thiol peroxidases involved in peroxide reduction. Mitochondrial Prx3 and Prx5 are involved in the enzymatic degradation of H₂O₂, organic hydroperoxides, and ONOO⁻ (46, 139). Prx3 belongs to the typical 2-cysteine class of Prx (38) and is the target of up to 90% of H₂O₂ generated in the mitochondrial matrix with a high reaction rate (2×10⁷ M ⁻¹·s⁻¹) especially at low levels of H₂O₂ (36, 38, 148). Accordingly, overexpression of Prx-3 reduces H₂O₂ production and lipid peroxidation and protects cells from different inducers of apoptosis such as hypoxia, TNFα, cadmium, and oxidant-generating drugs (19, 21, 131, 188). Prx3 is overexpressed in human breast cancers (129) and, hence, it prevents apoptosis induced either by radiation therapy or cisplatin (31). Conversely, Prx3 knockdown leads to increased mitochondrial oxidant production and protein carbonyl content, altered mitochondrial morphology, and renders cells susceptible to apoptosis (19, 44, 60, 101, 120). Prx3 levels are found significantly lower in brains of Alzheimer's disease patients (91) and deficiency in Prx3 is also associated with amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Down syndrome (94, 192), thus emphasizing the significance of mitochondrial Prx in neurodegenerative disorders. Mitochondrial Prx5, a 17 kDa atypical 2-Cys Prx (157), is less effective than Prx3 in reducing H₂O₂ but has a higher reactivity towards ONOO⁻ (173). Overexpression of the Prx5 inhibits H₂O₂ accumulation, TNFα-induced JNK activation, H₂O₂-induced DNA damage, and p53-induced apoptosis (11, 12, 205), whereas Prx5-deficient cells show higher levels of protein and DNA oxidative damage and are more susceptible to apoptosis (44, 96, 146).

Regulation of mitochondrial Prx activity is performed at the level of gene expression and by its oxidation (73, 194). A disrupted mitochondrial redox status activates transcription of Prx3 by FOXO3a, nuclear factor erythroid 2-related factor (Nrf2), and PGC1α, and adaptively strengthens antioxidant defenses (7, 28, 134). Post-translationally, Prx3 oxidation is found as an early event during receptor-mediated apoptosis, which leads to increased mitochondrial H₂O₂ levels and further affects assembly of the apoptotic machinery (37).

Prxs are considered important regulators of the cellular H₂O₂ steady-state levels: for the typical 2-Cys Prx (Prx1-3), the peroxidatic cysteine, Cys_P-SH, at the redox-sensitive N-terminal, is oxidized by H₂O₂ to Cys_P-SOH, followed by reaction with a nearby resolving cysteine (Cys_R-SH) at the N-terminal of the other subunit to form an intermolecular disulfide and release H₂O. This disulfide is then reduced by Trxs. At high concentrations of H₂O₂, oxidation of the intermediate Prx-Cys-SOH to Prx-Cys-SO₂H (sulfinic acid form) results in loss of peroxidase activity (35). Sulfiredoxin (Srx) can reduce the sulfinic acid form of Prx back to Prx-Cys-SOH (189). Mammalian Srx translocates to mitochondria under oxidative conditions to reduce over-oxidized mitochondrial Prx3 (130, 190) in an ATP-driven reaction followed by binding of Srx to 2-Cys Prx enzymes and release of the γ-phosphate from ATP to the sulfinic moiety and reduction of the resulting sulfinic phosphoryl ester by either mitochondrial GSH or thioredoxin (20, 74, 83, 149, 153) (Fig. 6).

FIG. 6.

The mitochondrial peroxiredoxin–sulfiredoxin system in the recovery of hyperoxidized peroxiredoxin. Mitochondrial peroxiredoxin-3 is a typical 2 cysteine peroxiredoxin. The scheme shows only modifications of one Cys-S_P of peroxiredoxin. This mechanism is based on References 20, 74, 83, 149, and 153.

Expression of Srx is primarily regulated by the Nrf2 (10, 138, 164) along with other phase II enzymes: Trx, Prx, GPx, and MnSOD. In addition to Nrf2, the expression of Srx is also regulated by AP-1 in pancreatic β-cells (53) and in rat neurons (183). Hence, Srx expression is induced in various oxidative and nitrosative stress conditions and is seen as an adaptive and protective mechanism to avoid sustained excessive oxidant production due to hyperoxidation of Prx and its inactivation (1, 9, 10, 164). Currently, the major role of Srx is to catalyze the reversible sulfinic modification of 2-Cys Prxs but not the sulfinic acid form of other over-oxidized proteins such as GAPDH and DJ-1 (149). The biological significance of this reversible hyperoxidation of Prx enzymes is still unclear: it has been proposed that inactivation of Prx by over-oxidation results in higher levels of H₂O₂, which may be engaged in regulation of distinct signaling pathways (193); albeit attractive, this proposal needs to be viewed in light of the spatial considerations for H₂O₂ signaling (82, 178). Srx^−/− mice show normal viability but an increased mortality during endotoxic shock; this may suggest a protective role of Srx through regulation of Prx function and cellular H₂O₂ levels (141).

The reducing power for Prx is transmitted through thiols of the Trx system: NADPH→TrxR→Trx→Prx (65, 199). Trx is highly efficient in redox reactions via thiol-disulfide exchanges (108, 118, 143), thus impacting cellular functions such as antioxidant defenses and redox control of transcription and signal transduction (8, 66). Trx is also involved in the reduction of methionine sulfoxides via methionine sulfoxide reductases (MSR). Mitochondrial Trx2 is found at its highest levels in metabolically active tissues (18, 167) and its oxidation after exposure to peroxides and diamide is an early event in oxidative stress; overexpression of Trx2 increases mitochondrial membrane potential, inhibits cytochrome c release from mitochondria (42), and protects the cells against TNFα-, diamide-, and tert-butylhydroperoxide-induced oxidation, cytotoxicity, and cell death (22, 23, 59). Trx-2-deficient cells show accumulation of intracellular oxidants, cytochrome c release, and activation of the intrinsic apoptotic pathway (169) and Trx2^−/− mice show increased apoptosis in early embryos leading to embryonic lethality (132) that coincides with mitochondria maturation. This strengthens the association of mitochondrial metabolic function and oxidant regulation (i.e., the mitochondrial energy–redox axis). This is also supported by studies showing that Trx2^+/− mice show reduced ATP production and electron-transport chain complexes activities (140). Knocking down TrxR leads to Trx2 oxidation and this sensitizes cells to oxidant-induced cell death (152). The mitochondrial generation of oxidants and the reducing power of TrxR2 determine the redox status of Trx2, which can be viewed as a marker of mitochondrial dysfunction and oxidant-induced cell death (81, 82, 87, 124).

Trx2 may be involved in the regulation of apoptosis through its interaction with Apoptosis Signal-regulating Kinase 1 (ASK1) (200). Upon pro-inflammatory cytokine (TNFα) or oxidative stress (H₂O₂) stimulation, mitochondrion-localized ASK1 disassociates from Trx2 and mediates a JNK-independent caspase-mediated apoptotic pathway (200). Overexpression of Trx2 inhibits ASK1-induced apoptosis, while knockdown of Trx2 increases TNFα/ASK1-induced cytochrome c release (156, 200). The mitochondrial permeability transition (MPT) plays significant roles in activation of apoptosis and necrosis (72, 144, 174, 198): Trx2 protects isolated mitochondria from MPT induced by peroxide or Ca⁺⁺ (61) and Trx2-deficient cells show lower mitochondrial membrane potential (182). Whether Trx2 regulates the MPT by either interacting with MPT pore or modulating the mitochondrial oxidant levels is still unclear (61). Mitochondrial GSH also plays an important role in maintaining mitochondrial inner membrane permeability (111). The association of Trx2 with cytochrome c both in vivo and in vitro could provide a mechanism for the inhibitory role of Trx2 in apoptotic signaling (169). Taken together, the interactions involving Trx2, ASK1, cytochrome c, and MPT seem to be critical in the regulation of mitochondria-mediated apoptotic pathway.

Mitochondrial GSH in Cell Viability and Function

The properties and roles of mitochondrial GSH were first studied during the mid-1960s to mid-1970s (77, 78) and then advanced in the 1980s (115), showing the role of mitochondrial GSH in maintaining cell viability. Depletion of mitochondrial GSH decreased the cellular viability (158), whereas increasing mitochondrial GSH protected against oxidative and nitrosative stress (121). Increased mitochondrial GSH oxidation and decreased GSH/GSSG ratios as a function of age were accompanied by oxidative damage of the mtDNA (43, 165, 166, 181).

In the central nervous system, mitochondrial GSH depletion in astrocytes led to cell death via necrosis rather than apoptosis and decreases in mitochondrial GSH below 50% resulted in neuronal degeneration (69, 122). Expectedly, loss of mitochondrial GSH in neurons was accompanied by increase in oxidant levels, collapse of mitochondrial membrane potential, and cell death (195). The chemoprotectant 3H-1,2-dithiole-3-thione protected against oxidative and electrophilic neurotoxicity in neuroblastoma cells and primary neurons due to its ability to increase mitochondrial GSH (76). Interestingly, dopamine at nontoxic concentrations strongly increased mitochondrial GSH and afforded a greater protection against cytotoxicity (75). GSH was substantially decreased in cerebral cortex and striatum mitochondria in a model of brain focal ischemia, in which the loss in mitochondrial GSH did not correlate with minimal total GSH losses in the tissue (4). In this model, bilateral injections of GSH monoethylester—prior to induction of unilateral focal ischemia—increased mitochondrial GSH in the striatum of ischemic and nonischemic hemispheres, albeit with no reduction of infarct volume. This could be potentially used to study the effects of modulating brain mitochondrial glutathione in a range of brain disorders and warrants further research (3). The above studies establish the importance of the role of mitochondrial GSH in maintaining brain function.

In liver, TNF-α increased the susceptibility of hepatocytes after mitochondrial GSH depletion and restoration of mitochondrial GSH levels had protective effects against TNF-α (32). Decreased intracellular GSH levels markedly enhance the cytotoxicity of alkylating agents; however, it shifts the mode of cell death to necrosis rather than apoptosis. This study poses an important question as to whether raising GSH levels enables the switch from necrosis to apoptosis, thus viewing apoptosis as a more desirable cell death pathway that circumvents the destructive inflammatory response associated with necrosis (49).

Mitochondria have also been shown to undergo morphological and functional changes in chronic experimental models of alcoholism in which ethanol is oxidized to acetaldehyde in liver (168). In chronic models of alcoholism, there is a distinct mitochondrial damage characterized by abnormalities like its swelling, disruption, disorganization of the normal cristae organization, all of which finally translates into a lower energy-transducing capacity (i.e., ATP levels) (17, 39, 168). These effects stem partly from a low mitochondrial GSH pool, as a consequence of dysfunctional GSH transport into the mitochondria, which weakens binding of cytochrome c to cardiolipin in the inner mitochondrial membrane and affects membrane permeabilization (84, 110, 135). Decreased mitochondrial GSH is also linked to disrupted Ca⁺⁺ homeostasis via disturbances in the pyridine nucleotide pool mainly caused by decreased mitochondrial GSH (99, 106).

The transport of GSH into mitochondria was found to be closely associated with the apoptotic machinery due to the interaction of GSH with the BH3 groove of Bcl-2; pro-apoptotic Bax and BH3-only proteins suppressed GSH transport into the mitochondria upon inhibition of GSH-Bcl-2 binding (206). Bcl-2 binding to GSH enhanced its affinity for the 2-oxoglutarate carrier on the inner mitochondrial membrane (187).

Conclusions and Perspectives

The interlaced networks of mitochondrial thiols constitute a regulatory device to maintain mitochondrial redox status and modulate cytosolic redox signaling in normal and stress conditions. Disturbances in this regulatory device can affect transcription, growth, and ultimately influences cell survival/death. Modification of sulhydryl groups on signal proteins by oxidants and their control exerted by thiol-containing molecules such as glutathione, Grx, Trx, and Prx, forms the core of redox signaling. Each of them plays a distinct role in the overall process. GSH/GSSG determines the mitochondrial redox status due to its high molecular concentration and can be seen as a “redox buffer”; Prx3 acts more in H₂O₂ removal and therefore affects the H₂O₂ signal pathway as a “redox sensor”; Trx2 acts more as a “redox transmitter” to transfer the reducing equivalents from NADPH to other thiol-molecules such as Prx3. The primary role of Grx2 in mitochondria is to control protein glutathionylation/deglutathionylation and thereby regulate functions of important mitochondrial enzymes in response to change in mitochondrial redox status. Mitochondrial thiols thereby form an intricate network that constitutes complex crosstalk involved in oxidants detoxification and maintenance of cellular and mitochondrial redox homeostasis, as well as the modulation of cytosolic redox-sensitive signaling and cell death. Emerging evidence suggests that the mitochondrial thiol/disulfide systems are critical for the progression of several pathologies (Table 1). Thus, the modulation of key mitochondrial thiol proteins, which participate in oxidative stress responses, redox signaling, maintenance of the bioenergetic machinery, and cell death programming, provides a pivotal direction in developing new therapies towards the prevention and treatment of these diseases.

Table 1.

Mitochondrial Thiols and Related Enzymatic Systems in Disease

	Thiols involved	References
Neurodegeneration
Models of Alzheimer's disease	Prx3, GSH	16, 55, 91
Models of Parkinson's disease	Grx1^*, Grx2, GSH, Protein-SSG, Prx3, Prx5	27, 44, 55, 60, 94, 98, 125, 155
Excitotoxicity	Prx3	60
Down syndrome	Prx3	91, 94
Liver diseases
Alcohol-induced hepatoxicity	Srx	9
Alcoholic steatohepatitis	GSH	33, 105, 201, 202
Nonalcoholic steatohepatitis	GSH	109
Chronic alcoholism	GSH	50
Acetaminophen toxicity	GSH	179, 201
Liver cirrhosis	GSH	93
Cardiovascular diseases
Ischemic preconditioning	Protein-SSG, Protein-SNO	24, 62
Dilated cardiomyopathy	TrxR2	160
Myocardial infarction	Prx3	7
Vascular muscle function	Protein-SSG	63
Diabetes
Glucose tolerance	Prx3	21
Diabetic retinopathy	GSH	86
Cancer
Hepatocellular carcinomas	TrxR2, Prx3	29
Human breast cancer	Prx3	129
Colon cancer cell protection	Prx3	131
Neoplastic transformation	Prx3	188
Aging	GSH, Prx5	43, 146, 165, 181
Stroke - Focal cerebral ischemia	GSH	3, 163

The table summarizes the involvement of selective mitochondrial thiols in different disease models addressed in this review. ^*Glutaredoxin-1 in the inter-membrane space.

Footnotes

Acknowledgments

This study is supported by National Institutes of Health Grants R01AG016718 and P01AG026572 (to Roberta Díaz Brinton; Project 1 to EC) and Grant 17RT-0171.

Author Disclosure Statement

No competing financial interests exist.

Abbreviations Used

References

Abbas

, Breton

, Planson

, Bouton

, Bignon

, Seguin

, Riquier

, Toledano

, Drapier

. Nitric oxide activates an Nrf2/sulfiredoxin antioxidant pathway in macrophages. Free Radic Biol Med, 51:107–114. 2011.

Andersen

. Oxidative stress in neurodegeneration: Cause or consequence? Nat Med, 10:S18–25. 2004.

Anderson

, Nilsson

, Sims

. Glutathione monoethylester prevents mitochondrial glutathione depletion during focal cerebral ischemia. Neurochem Int, 44:153–159. 2004.

Anderson

, Sims

. The effects of focal ischemia and reperfusion on the glutathione content of mitochondria from rat brain subregions. J. Neurochem, 81:541–549. 2002.

Antunes

, Cadenas

. Estimation of H₂O₂ gradients across biomembranes. FEBS Lett, 475:121–126. 2000.

Antunes

, Cadenas

. Cellular titration of apoptosis with steady state concentrations of H₂O₂: Submicromolar levels of H₂O₂ induce apoptosis through Fenton chemistry independent of the cellular thiol state. Free Radic Biol Med, 30:1008–1018. 2001.

Araki

, Nanri

, Ejima

, Murasato

, Fujiwara

, Nakashima

, Ikeda

. Antioxidant function of the mitochondrial protein SP-22 in the cardiovascular system. J Biol Chem, 274:2271–2278. 1999.

Aslund

, Beckwith

. Bridge over troubled waters: sensing stress by disulfide bond formation. Cell, 96:751–3. 1999.

Bae

, Sung

, Cho

, Lee

, Woo

, Yu

, Kil

, Rhee

. Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol-induced oxidative injury in mouse liver. Hepatology, 53:945–953. 2011.

10.

Bae

, Woo

, Sung

, Lee

, Kil

, Rhee

. Induction of sulfiredoxin via an Nrf2-dependent pathway and hyperoxidation of peroxiredoxin III in the lungs of mice exposed to hyperoxia. Antioxid Redox Signal, 11:937–948. 2009.

11.

Banmeyer

, Marchand

, Clippe

, Knoops

. Human mitochondrial peroxiredoxin 5 protects from mitochondrial DNA damages induced by hydrogen peroxide. FEBS Lett, 579:2327–2333. 2005.

12.

Banmeyer

, Marchand

, Verhaeghe

, Vucic

, Rees

, Knoops

. Overexpression of human peroxiredoxin 5 in subcellular compartments of Chinese hamster ovary cells: Effects on cytotoxicity and DNA damage caused by peroxides. Free Radic Biol Med, 36:65–077. 2004.

13.

Barnham

, Masters

, Bush

. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov, 3:205–214. 2004.

14.

Beal

. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol, 38:357–366. 1995.

15.

Beer

, Taylor

, Brown

, Dahm

, Costa

, Runswick

, Murphy

. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: Implications for mitochondrial redox regulation and antioxidant defense. J Biol Chem, 279:47939–47951. 2004.

16.

Boyd-Kimball

, Sultana

, Abdul

, Butterfield

. Gamma-glutamylcysteine ethyl ester-induced up-regulation of glutathione protects neurons against Abeta(1–42)-mediated oxidative stress and neurotoxicity: Implications for Alzheimer's disease. J Neurosci Res, 79:700–706. 2005.

17.

Bruguera

, Bertran

, Bombi

, Rodes

. Giant mitochondria in hepatocytes: A diagnostic hint for alcoholic liver disease. Gastroenterology, 73:1383–1387. 1977.

18.

Chae

, Kim

, Kang

, Rhee

. Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Res Clin Pract, 45:101–112. 1999.

19.

Chang

, Cho

, Park

, Yu

, Kang

, Rhee

. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J Biol Chem, 279:41975–41984. 2004.

20.

Chang

, Jeong

, Woo

, Lee

, Park

, Rhee

. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J Biol Chem, 279:50994–51001. 2004.

21.

Chen

, Na

, Gu

, Salmon

, Liu

, Liang

, Qi

, Van Remmen

, Richardson

, Ran

. Reduction of mitochondrial H₂O₂ by overexpressing peroxiredoxin 3 improves glucose tolerance in mice. Aging Cell, 7:866–878. 2008.

22.

Chen

, Cai

, Jones

. Mitochondrial thioredoxin in regulation of oxidant-induced cell death. FEBS Lett, 580:6596–6602. 2006.

23.

Chen

, Cai

, Murphy

, Jones

. Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J Biol Chem, 277:33242–33248. 2002.

24.

Chen

, Chen

, Pfeiffer

, Zweier

. Mitochondrial complex II in the post-ischemic heart: Oxidative injury and the role of protein S-glutathionylation. J Biol Chem, 282:32640–32654. 2007.

25.

Chen

, Lash

. Evidence for mitochondrial uptake of glutathione by dicarboxylate and 2-oxoglutarate carriers. J Pharmacol Exp Ther, 285:608–618. 1998.

26.

Chen

, Putt

, Lash

. Enrichment and functional reconstitution of glutathione transport activity from rabbit kidney mitochondria: Further evidence for the role of the dicarboxylate and 2-oxoglutarate carriers in mitochondrial glutathione transport. Arch Biochem Biophys, 373:193–202. 2000.

27.

Chinta

, Andersen

. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: Implications for Parkinson's disease. Free Radic Biol Med, 41:1442–1448. 2006.

28.

Chiribau

, Cheng

, Cucoranu

, Yu

, Clempus

, Sorescu

. FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts. J Biol Chem, 283:8211–8217. 2008.

29.

Choi

, Kim

, Baek

, Kim

, Lee

, Kim

. Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res, 22:3331–3335. 2002.

30.

Chrestensen

, Starke

, Mieyal

. Acute cadmium exposure inactivates thioltransferase (glutaredoxin), inhibits intracellular reduction of protein-glutathionyl-mixed disulfides, and initiates apoptosis. J Biol Chem, 275:26556–26565. 2000.

31.

Chung

, Yoo

, Park

, Kim

. Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Res, 21:1129–1133. 2001.

32.

Colell

, Garcia-Ruiz

, Miranda

, Ardite

, Mari

, Morales

, Corrales

, Kaplowitz

, Fernandez-Checa

. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology, 115:1541–1551. 1998.

33.

Coll

, Colell

, Garcia-Ruiz

, Kaplowitz

, Fernandez-Checa

. Sensitivity of the 2-oxoglutarate carrier to alcohol intake contributes to mitochondrial glutathione depletion. Hepatology, 38:692–702. 2003.

34.

Costa

, Dahm

, Hurrell

, Taylor

, Murphy

. Interactions of mitochondrial thiols with nitric oxide. Antioxid Redox Signal, 5:291–305. 2003.

35.

Cox

, Pearson

, Pullar

, Jonsson

, Lowther

, Winterbourn

, Hampton

. Mitochondrial peroxiredoxin 3 is more resilient to hyperoxidation than cytoplasmic peroxiredoxins. Biochem J, 421:51–58. 2009.

36.

Cox

, Peskin

, Paton

, Winterbourn

, Hampton

. Redox potential and peroxide reactivity of human peroxiredoxin 3. Biochemistry, 48:6495–6501. 2009.

37.

Cox

, Pullar

, Hughes

, Ledgerwood

, Hampton

. Oxidation of mitochondrial peroxiredoxin 3 during the initiation of receptor-mediated apoptosis. Free Radic Biol Med, 44:1001–1009. 2008.

38.

Cox

, Winterbourn

, Hampton

. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem J, 425:313–325. 2010.

39.

Cunningham

, Bailey

. Ethanol consumption and liver mitochondria function. Neurosignals, 10:271–282. 2001.

40.

Dalle-Donne

, Colombo

, Gagliano

, Colombo

, Giustarini

, Rossi

, Milzani

. S-glutathiolation in life and death decisions of the cell. Free Radic Res., 45:3–15. 2011.

41.

Dalle-Donne

, Milzani

, Gagliano

, Colombo

, Giustarini

, Rossi

. Molecular mechanisms and potential clinical significance of S-glutathionylation. Antioxid. Redox Signal, 10:445–473. 2008.

42.

Damdimopoulos

, Miranda-Vizuete

, Pelto-Huikko

, Gustafsson

, Spyrou

. Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death. J Biol Chem, 277:33249–33257. 2002.

43.

de la Asuncion

, Millan

, Pla

, Bruseghini

, Esteras

, Pallardo

, Sastre

, Vina

. Mitochondrial glutathione oxidation correlates with age-associated oxidative damage to mitochondrial DNA. FASEB J, 10:333–338. 1996.

44.

De Simoni

, Goemaere

, Knoops

. Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP⁺ Neurosci Lett, 433:219–224. 2008.

45.

Deneke

, Fanburg

. Regulation of cellular glutathione. Am J Physiol., 257:L163–L173. 1989.

46.

Dubuisson

, Vander Stricht

, Clippe

, Etienne

, Nauser

, Kissner

, Koppenol

, Rees

, Knoops

. Human peroxiredoxin 5 is a peroxynitrite reductase. FEBS Lett, 571:161–165. 2004.

47.

Ehrhart

, Gluck

, Mieyal

, Zeevalk

. Functional glutaredoxin (thioltransferase) activity in rat brain and liver mitochondria. Parkinsonism Relat Disord, 8:395–400. 2002.

48.

Enoksson

, Fernandes

, Prast

, Lillig

, Holmgren

, Orrenius

. Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. Biochem Biophys Res Commun, 327:774–779. 2005.

49.

Fernandes

, Cotter

. Apoptosis or necrosis: Intracellular levels of glutathione influence mode of cell death. Biochem Pharmacol, 48:675–681. 1994.

50.

Fernandez-Checa

, Garcia-Ruiz

, Ookhtens

, Kaplowitz

. Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats. Tracer kinetic studies in vitro and in vivo and susceptibility to oxidant stress. J Clin Invest, 87:397–405. 1991.

51.

Garcia

, Han

, Sancheti

, Yap

, Kaplowitz

, Cadenas

. Regulation of mitochondrial glutathione redox status and protein glutathionylation by respiratory substrates. J Biol Chem, 285:39646–39654. 2010.

52.

Gladyshev

, Liu

, Novoselov

, Krysan

, Sun

, Kryukov

, Lou

. Identification and characterization of a new mammalian glutaredoxin (thioltransferase), Grx2. J Biol Chem, 276:30374–30380. 2001.

53.

Glauser

, Brun

, Gauthier

, Schlegel

. Transcriptional response of pancreatic beta cells to metabolic stimulation: Large scale identification of immediate-early and secondary response genes. BMC Mol Biol, 8:54. 2007.

54.

Griffith

, Meister

. Origin and turnover of mitochondrial glutathione. Proc Natl Acad Sci USA, 82:4668–4672. 1985.

55.

, Owen

, Toffa

, Cooper

, Dexter

, Jenner

, Marsden

, Schapira

. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. J Neurol Sci, 158:24–29. 1998.

56.

This reference has been deleted.

57.

Han

, Canali

, Garcia

, Aguilera

, Gallaher

, Cadenas

. Sites and mechanisms of aconitase inactivation by peroxynitrite: Modulation by citrate and glutathione. Biochemistry, 44:11986–11996. 2005.

58.

Hansen

, Go

, Jones

. Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. Annu Rev Pharmacol Toxicol, 46:215–234. 2006.

59.

Hansen

, Zhang

, Jones

. Mitochondrial thioredoxin-2 has a key role in determining tumor necrosis factor-alpha-induced reactive oxygen species generation, NF-kappaB activation, and apoptosis. Toxicol Sci, 91:643–650. 2006.

60.

Hattori

, Murayama

, Noshita

, Oikawa

. Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo. J Neurochem, 86:860–868. 2003.

61.

, Cai

, Go

, Johnson

, Martin

, Hansen

, Jones

. Identification of thioredoxin-2 as a regulator of the mitochondrial permeability transition. Toxicol Sci, 105:44–50. 2008.

62.

Hill

, Darley-Usmar

. S-nitrosation and thiol switching in the mitochondrion: A new paradigm for cardioprotection in ischaemic preconditioning. Biochem J, 412:e11–13. 2008.

63.

Hill

, Higdon

, Dranka

, Darley-Usmar

. Regulation of vascular smooth muscle cell bioenergetic function by protein glutathiolation. Biochim Biophys Acta., 1797:285–295. 2010.

64.

Hoek

, Rydström

. Physiological roles of nicotinamide nucleotide transhydrogenase. Biochem J, 254:1–10. 1988

65.

Hofmann

, Hecht

, Flohe

. Peroxiredoxins. Biol Chem, 383:347–364. 2002.

66.

Holmgren

. Thioredoxin and glutaredoxin systems. J Biol Chem, 264:13963–13966. 1989.

67.

Holmgren

, Aslund

. Glutaredoxin. Methods Enzymol, 252:283–292. 1995.

68.

Holmgren

, Johansson

, Berndt

, Lonn

, Hudemann

, Lillig

. Thiol redox control via thioredoxin and glutaredoxin systems. Biochem Soc Trans, 33:1375–1377. 2005.

69.

Huang

, Philbert

. Cellular responses of cultured cerebellar astrocytes to ethacrynic acid-induced perturbation of subcellular glutathione homeostasis. Brain Res, 711:184–192. 1996.

70.

Hurd

, Costa

, Dahm

, Beer

, Brown

, Filipovska

, Murphy

. Glutathionylation of mitochondrial proteins. Antioxid Redox Signal, 7:999–1010. 2005.

71.

Hwang

, Sinskey

, Lodish

. Oxidized redox state of glutathione in the endoplasmic reticulum. Science, 257:1496–1502. 1992.

72.

Imberti

, Nieminen

, Herman

, Lemasters

. Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: Protection by fructose, cyclosporin A and trifluoperazine. J Pharmacol Exp Ther, 265:392–400. 1993.

73.

Immenschuh

, Baumgart-Vogt

. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal, 7:768–777. 2005.

74.

Jeong

, Park

, Chang

, Lee

, Rhee

. Molecular mechanism of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin. J Biol Chem, 281:14400–14407. 2006.

75.

Jia

, Zhu

, Misra

, Li

, Misra

. Dopamine as a potent inducer of cellular glutathione and NAD(P)H:quinone oxidoreductase 1 in PC12 neuronal cells: A potential adaptive mechanism for dopaminergic neuroprotection. Neurochem Res., 33:2197–2205. 2008.

76.

Jia

, Zhu

, Misra

, Li

. Potent induction of total cellular GSH and NQO1 as well as mitochondrial GSH by 3H-1,2-dithiole-3-thione in SH-SY5Y neuroblastoma cells and primary human neurons: Protection against neurocytotoxicity elicited by dopamine, 6-hydroxydopamine, 4-hydroxy-2-nonenal, or hydrogen peroxide. Brain Res, 1197:159–169. 2008.

77.

Jocelyn

. Some properties of mitochondrial glutathione. Biochim Biophys Acta, 396:427–436. 1975.

78.

Jocelyn

, Dickson

. Glutathione and the mitochondrial reduction of hydroperoxides. Biochim Biophys Acta, 590:1–12. 1980.

79.

Johansson

, Lillig

, Holmgren

. Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J Biol Chem, 279:7537–7543. 2004.

80.

Jones

. Redox potential of GSH/GSSG couple: Assay and biological significance. Methods Enzymol. Helmut

, Lester

. Academic Press, 2002; 93–112.

81.

Jones

. Disruption of mitochondrial redox circuitry in oxidative stress. Chem Biol Interact, 163:38–53. 2006.

82.

Jones

. Redox sensing: Orthogonal control in cell cycle and apoptosis signalling. J Intern Med, 268:432–448. 2010.

83.

Jonsson

, Murray

, Johnson

, Poole

, Lowther

. Structural basis for the retroreduction of inactivated peroxiredoxins by human sulfiredoxin. Biochemistry, 44:8634–8642. 2005.

84.

Kagan

, Tyurin

, Jiang

, Tyurina

, Ritov

, Amoscato

, Osipov

, Belikova

, Kapralov

, Kini

, Vlasova

, Zhao

, Zou

, Di

, Svistunenko

, Kurnikov

, Borisenko

. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol, 1:223–232. 2005.

85.

Kaneto

, Kawamori

, Matsuoka

, Kajimoto

, Yamasaki

. Oxidative stress and pancreatic beta-cell dysfunction. Am J Ther, 12:529–533. 2005.

86.

Kanwar

, Chan

, Kern

, Kowluru

. Oxidative damage in the retinal mitochondria of diabetic mice: Possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci, 48:3805–3811. 2007.

87.

Kemp

, Go

, Jones

. Nonequilibrium thermodynamics of thiol/disulfide redox systems: A perspective on redox systems biology. Free Radic Biol Med, 44:921–937. 2008.

88.

Kenchappa

, Ravindranath

. Glutaredoxin is essential for maintenance of brain mitochondrial complex I: Studies with MPTP. FASEB J, 17:717–719. 2003.

89.

Kerr

JFR

, Winterford

, Harmon

. Apoptosis. Its significance in cancer and cancer therapy. Cancer, 73:2013–2026. 1994.

90.

Kil

, Park

. Regulation of mitochondrial NADP⁺-dependent isocitrate dehydrogenase activity by glutathionylation. J Biol Chem, 280:10846–10854. 2005.

91.

Kim

, Fountoulakis

, Cairns

, Lubec

. Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndrome. J Neural Transm Suppl, 61:223–235. 2001.

92.

Klatt

, Lamas

. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. Eur J Biochem, 267:4928–4944. 2000.

93.

Krahenbuhl

, Talos

, Lauterburg

, Reichen

. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology, 22:607–612. 1995.

94.

Krapfenbauer

, Engidawork

, Cairns

, Fountoulakis

, Lubec

. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res, 967:152–160. 2003.

95.

Kroemer

, Dallaporta

, Resche-Rigon

. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol., 60:619–642. 1998.

96.

Kropotov

, Gogvadze

, Shupliakov

, Tomilin

, Serikov

, Tomilin

, Zhivotovsky

. Peroxiredoxin V is essential for protection against apoptosis in human lung carcinoma cells. Exp Cell Res, 312:2806–2815. 2006.

97.

Lash

. Mitochondrial glutathione transport: Physiological, pathological and toxicological implications. Chem Biol Interact., 163:54–67. 2006.

98.

Lee

, Kaur

, Chinta

, Rajagopalan

, Andersen

. A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: Implications for Parkinson's disease. Antioxid Redox Signal, 11:2083–2094. 2009.

99.

Lehninger

, Vercesi

, Bababunmi

. Regulation of Ca²⁺ release from mitochondria by the oxidation-reduction state of pyridine nucleotides. Proc Natl Acad Sci USA, 75:1690–1694. 1978.

100.

Leist

, Single

, Castoldi

, Kuhnle

, Nicotera

. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J Exp Med., 185:1481–1486. 1997.

101.

, Shoji

, Takano

, Nishimura

, Aoki

, Takahashi

, Goto

, Kaifu

, Takai

, Obinata

. Increased susceptibility of MER5 (peroxiredoxin III) knockout mice to LPS-induced oxidative stress. Biochem Biophys Res Commun, 355:715–721. 2007.

102.

Lillig

, Holmgren

. Thioredoxin and related molecules—From biology to health and disease. Antioxid Redox Signal, 9:25–47. 2007.

103.

Lillig

, Lonn

, Enoksson

, Fernandes

, Holmgren

. Short interfering RNA-mediated silencing of glutaredoxin 2 increases the sensitivity of HeLa cells toward doxorubicin and phenylarsine oxide. Proc Natl Acad Sci USA, 101:13227–13232. 2004.

104.

Liu

, Kim

, Yang

, Jemmerson

, Wang

. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell, 86:147–157. 1996.

105.

Lluis

, Colell

, Garcia-Ruiz

, Kaplowitz

, Fernandez-Checa

. Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress. Gastroenterology, 124:708–724. 2003.

106.

Lötscher

, Winterhalter

, Carafoli

, Richter

. Hydroperoxide-induced loss of pyridine nucleotides and release of calcium from rat liver mitochondria. J Biol Chem, 255:9325–9330. 1980.

107.

Lowell

, Shulman

. Mitochondrial dysfunction and type 2 diabetes. Science, 307:384–387. 2005.

108.

Maher

. Redox control of neural function: Background, mechanisms, and significance. Antioxid Redox Signal, 8:1941–1970. 2006.

109.

Mari

, Caballero

, Colell

, Morales

, Caballeria

, Fernandez

, Enrich

, Fernandez-Checa

, Garcia-Ruiz

. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab, 4:185–198. 2006.

110.

Marí

, Morales

, Colell

, García-Ruiz

, Fernández-Checa

. Mitochondrial glutathione, a key survival antioxidant. Antioxid Redox Signal, 11:2685–2700. 2009.

111.

Masini

, Ceccarelli

, Trenti

, Gallesi

, Muscatello

. Mitochondrial inner membrane permeability changes induced by octadecadienoic acid hydroperoxide. Role of mitochondrial GSH pool. Biochim Biophys Acta, 1101:84–89. 1992.

112.

Mattson

, Magnus

. Ageing and neuronal vulnerability. Nat Rev Neurosci, 7:278–294. 2006.

113.

McKernan

, Woods

, Lash

. Uptake of glutathione by renal cortical mitochondria. Arch Biochem Biophys, 288:653–663. 1991.

114.

Mehendale

, Roth

, Gandolfi

, Klaunig

, Lemasters

, Curtis

. Novel mechanisms in chemically induced hepatotoxicity. FASEB J, 8:1285–1295. 1994.

115.

Meredith

, Reed

. Depletion in vitro of mitochondrial glutathione in rat hepatocytes and enhancement of lipid peroxidation by adriamycin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Biochem. Pharmacol., 32:1383–1388. 1983.

116.

Allen

EMG

, Mieyal

. Protein-thiol oxidation and cell death: Regulatory role of glutaredoxins. Antioxid Redox Signal, 17:1748–1763. 2012.

117.

Miller

, Dickinson

, Chang

. Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signaling. Proc Natl Acad Sci USA, 107:15681–15686. 2010.

118.

Miranda-Vizuete

, Damdimopoulos

, Spyrou

. The mitochondrial thioredoxin system. Antioxid Redox Signal, 2:801–810. 2000.

119.

Moran

, Gutteridge

, Quinlan

. Thiols in cellular redox signalling and control. Curr Med Chem, 8:763–772. 2001.

120.

Mukhopadhyay

, Leung

, Hicks

, Hastings

, Youssoufian

, Plon

. Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia. J Cell Biol, 175:225–235. 2006.

121.

Muyderman

, Nilsson

, Sims

. Highly selective and prolonged depletion of mitochondrial glutathione in astrocytes markedly increases sensitivity to peroxynitrite. J Neurosci, 24:8019–8028. 2004.

122.

Muyderman

, Wadey

, Nilsson

, Sims

. Mitochondrial glutathione protects against cell death induced by oxidative and nitrative stress in astrocytes. J Neurochem, 102:1369–1382. 2007.

123.

Nagy

, Malik

, Tosaki

, Ho

, Maulik

, Das

. Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis. J Mol Cell Cardiol, 44:252–60. 2008.

124.

Nalvarte

, Damdimopoulos

, Spyrou

. Human mitochondrial thioredoxin reductase reduces cytochrome c and confers resistance to complex III inhibition. Free Radic Biol Med, 36:1270–1278. 2004.

125.

Naoi

, Maruyama

, Yi

, Yamaoka

, Shamoto-Nagai

, Akao

, Gerlach

, Tanaka

, Riederer

. Neuromelanin selectively induces apoptosis in dopaminergic SH-SY5Y cells by deglutathionylation in mitochondria: Involvement of the protein and melanin component. J Neurochem, 105:2489–2500. 2008.

126.

Navarro

, Boveris

. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol, 292:C670–686. 2007.

127.

Navarro

, Boveris

. Mitochondrial nitric oxide synthase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants. Adv Drug Deliv Rev, 60:1534–1544. 2008.

128.

Noctor

, Arisi

A-CM

, Jouanin

, Kunert

, Rennenberg

, Foyer

. Glutathione: Biosynthesis, metabolism and relationship to stress tolerance explored in transformed plants. J Exp Bot, 49:623–647. 1998.

129.

Noh

, Ahn

, Lee

, Kim

, Park

, Chae

. Overexpression of peroxiredoxin in human breast cancer. Anticancer Res, 21:2085–2090. 2001.

130.

Noh

, Baek

, Jeong

, Rhee

, Chang

. Sulfiredoxin translocation into mitochondria plays a crucial role in reducing hyperoxidized peroxiredoxin III. J Biol Chem, 284:8470–8477. 2009.

131.

Nonn

, Berggren

, Powis

. Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol Cancer Res, 1:682–689. 2003.

132.

Nonn

, Williams

, Erickson

, Powis

. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol Cell Biol, 23:916–922. 2003.

133.

Nulton-Persson

, Starke

, Mieyal

, Szweda

. Reversible inactivation of alpha-ketoglutarate dehydrogenase in response to alterations in the mitochondrial glutathione status. Biochemistry, 42:4235–4242. 2003.

134.

Olmos

, Valle

, Borniquel

, Tierrez

, Soria

, Lamas

, Monsalve

. Mutual dependence of Foxo3a and PGC-1alpha in the induction of oxidative stress genes. J Biol Chem, 284:14476–14484. 2009.

135.

Ott

, Robertson

, Gogvadze

, Zhivotovsky

, Orrenius

. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci USA, 99:1259–1263. 2002.

136.

Pacher

, Beckman

, Liaudet

. Nitric oxide and peroxynitrite in health and disease. Physiol Rev, 87:315–424. 2007.

137.

Pai

, Starke

, Lesnefsky

, Hoppel

, Mieyal

. What is the functional significance of the unique location of glutaredoxin 1 (GRx1) in the intermembrane space of mitochondria? Antioxid Redox Signal, 9:2027–2033. 2007.

138.

Papadia

, Soriano

, Leveille

, Martel

, Dakin

, Hansen

, Kaindl

, Sifringer

, Fowler

, Stefovska

, McKenzie

, Craigon

, Corriveau

, Ghazal

, Horsburgh

, Yankner

, Wyllie

, Ikonomidou

, Hardingham

. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci, 11:476–487. 2008.

139.

Peng

, Yang

, Guo

, Ng

, Liu

, Fung

, Tay

, Ge

, He

, Kung

, Lin

. Catalase and peroxiredoxin 5 protect Xenopus embryos against alcohol-induced ocular anomalies. Invest Ophthalmol Vis Sci, 45:23–29. 2004.

140.

Perez

, Lew

, Cortez

, Webb

, Rodriguez

, Liu

, Qi

, Li

, Chaudhuri

, Van Remmen

, Richardson

, Ikeno

. Thioredoxin 2 haploinsufficiency in mice results in impaired mitochondrial function and increased oxidative stress. Free Radic Biol Med, 44:882–892. 2008.

141.

Planson

, Palais

, Abbas

, Gerard

, Couvelard

, Delaunay

, Baulande

, Drapier

, Toledano

. Sulfiredoxin protects mice from lipopolysaccharide-induced endotoxic shock. Antioxid Redox Signal, 14:2071–2080. 2011.

142.

Poderoso

. The formation of peroxynitrite in the applied physiology of mitochondrial nitric oxide. Arch Biochem Biophys, 484:214–220. 2009.

143.

Powis

, Montfort

. Properties and biological activities of thioredoxins. Annu Rev Biophys Biomol Struct, 30:421–455. 2001.

144.

Precht

, Phelps

, Linseman

, Butts

, Le

, Laessig

, Bouchard

, Heidenreich

. The permeability transition pore triggers Bax translocation to mitochondria during neuronal apoptosis. Cell Death Differ, 12:255–265. 2005.

145.

Queiroga

, Almeida

, Martel

, Brenner

, Alves

, Vieira

. Glutathionylation of adenine nucleotide translocase induced by carbon monoxide prevents mitochondrial membrane permeabilization and apoptosis. J Biol Chem, 285:17077–17088. 2010.

146.

Radyuk

, Michalak

, Klichko

, Benes

, Rebrin

, Sohal

, Orr

. Peroxiredoxin 5 confers protection against oxidative stress and apoptosis and also promotes longevity in Drosophila. Biochem J, 419:437–445. 2009.

147.

Reed

. Glutathione: Toxicological implications. Annu Rev Pharmacol Toxicol., 30:603–631. 1990.

148.

Rhee

, Chae

, Kim

. Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med, 38:1543–1552. 2005.

149.

Rhee

, Jeong

, Chang

, Woo

. Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: Its discovery, mechanism of action, and biological significance. Kidney Int Suppl, 106:S3–8. 2007.

150.

Rhee

, Woo

. Multiple functions of peroxiredoxins: Peroxidases, sensors and regulators of the intracellular messenger HO, and protein chaperones. Antioxid Redox Signal, 15:781–794. 2011.

151.

Richter

, Schweizer

, Cossarizza

, Franceschi

. Control of apoptosis by the cellular ATP level. FEBS Lett, 378:107–110. 1996.

152.

Rohrbach

, Gruenler

, Teschner

, Holtz

. The thioredoxin system in aging muscle: Key role of mitochondrial thioredoxin reductase in the protective effects of caloric restriction? Am J Physiol Regul Integr Comp Physiol, 291:R927–935. 2006.

153.

Roussel

, Boukhenouna

, Rahuel-Clermont

, Branlant

. The rate-limiting step of sulfiredoxin is associated with the transfer of the gamma-phosphate of ATP to the sulfinic acid of overoxidized typical 2-Cys peroxiredoxins. FEBS Lett, 585:574–578. 2011.

154.

Rydstrom

. Mitochondrial NADPH, transhydrogenase, and disease. Biochim Biophys Acta, 1757:721–726. 2006.

155.

Saeed

, Durgadoss

, Valli

, Joshi

, Ravindranath

. Knockdown of cytosolic glutaredoxin 1 leads to loss of mitochondrial membrane potential: Implication in neurodegenerative diseases. PLoS One, 3:e2459. 2008.

156.

Saxena

, Chen

, Shalev

. Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein. J Biol Chem, 285:3997–4005. 2010.

157.

Seo

, Kang

, Kim

, Baines

, Lee

, Rhee

. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem, 275:20346–20354. 2000.

158.

Shan

, Jones

, Hashmi

, Anders

. Selective depletion of mitochondrial glutathione concentrations by (R,S)-3-hydroxy-4-pentenoate potentiates oxidative cell death. Chem Res Toxicol., 6:75–81. 1993.

159.

Sheeran

, Rydstrom

, Shakhparonov

, Pestov

, Pepe

. Diminished NADPH transhydrogenase activity and mitochondrial redox regulation in human failing myocardium. Biochim Biophys Acta, 1797:1138–1148. 2010.

160.

Sibbing

, Pfeufer

, Perisic

, Mannes

, Fritz-Wolf

, Unwin

, Sinner

, Gieger

, Gloeckner

, Wichmann

, Kremmer

, Schafer

, Walch

, Hinterseer

, Nabauer

, Kaab

, Kastrati

, Schomig

, Meitinger

, Bornkamm

, Conrad

, von Beckerath

. Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy. Eur Heart J, 32:1121–1133. 2011.

161.

Sies

, Moss

. A role of mitochondrial glutathione peroxidase in modulating mitochondrial oxidations in liver. Eur J Biochem, 84:377–383. 1978.

162.

Simonian

, Coyle

. Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol, 36:83–106. 1996.

163.

Sims

, Anderson

. Mitochondrial contributions to tissue damage in stroke. Neurochem Int, 40:511–526. 2002.

164.

Singh

, Ling

, Suhasini

, Zhang

, Yamamoto

, Navas-Acien

, Cosgrove

, Tuder

, Kensler

, Watson

, Biswal

. Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free Radic Biol Med, 46:376–386. 2009.

165.

Sohal

, Arnold

, Orr

. Effect of age on superoxide dismutase, catalase, glutathione reductase, inorganic peroxides, TBA-reactive material, GSH/GSSG, NADPH/NADP⁺ and NADH/NAD⁺ in Drosophila melanogaster. Mech Ageing Dev, 56:223–235. 1990.

166.

Sohal

, Dubey

. Mitochondrial oxidative damage, hydrogen peroxide release, and aging. Free Radic Biol Med, 16:621–626. 1994.

167.

Spyrou

, Enmark

, Miranda-Vizuete

, Gustafsson

. Cloning and expression of a novel mammalian thioredoxin. J Biol Chem, 272:2936–2941. 1997.

168.

Svoboda

, Manning

. Chronic alcoholism with fatty metamorphosis of the liver. Mitochondrial alterations in hepatic cells. Am J Pathol, 44:645–662. 1964.

169.

Tanaka

, Hosoi

, Yamaguchi-Iwai

, Nakamura

, Masutani

, Ueda

, Nishiyama

, Takeda

, Wada

, Spyrou

, Yodoi

. Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J, 21:1695–1703. 2002.

170.

Taylor

, Hurrell

, Shannon

, Lin

, Hirst

, Murphy

. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J Biol Chem, 278:19603–19610. 2003.

171.

Terada

. Specificity in reactive oxidant signaling: Think globally, act locally. J Cell Biol, 174:615–623. 2006.

172.

Thompson

. Apoptosis in the pathogenesis and treatment of disease. Science, 267:1456–1462. 1995.

173.

Trujillo

, Clippe

, Manta

, Ferrer-Sueta

, Smeets

, Declercq

, Knoops

, Radi

. Pre-steady state kinetic characterization of human peroxiredoxin 5: Taking advantage of Trp84 fluorescence increase upon oxidation. Arch Biochem Biophys, 467:95–106. 2007.

174.

Tsujimoto

, Nakagawa

, Shimizu

. Mitochondrial membrane permeability transition and cell death. Biochim Biophys Acta, 1757:1297–1300. 2006.

175.

Ueda

, Masutani

, Nakamura

, Tanaka

, Ueno

, Yodoi

. Redox control of cell death. Antioxid Redox Signal, 4:405–414. 2002.

176.

Valdez

, Zaobornyj

, Boveris

. Mitochondrial metabolic states and membrane potential modulate mtNOS activity. Biochim Biophys Acta, 1757:166–172. 2006.

177.

Van Remmen

, Jones

. Current thoughts on the role of mitochondria and free radicals in the biology of aging. J Gerontol A Biol Sci Med Sci, 64:171–174. 2009.

178.

Veal

, Day

. Hydrogen peroxide as a signaling molecule. Antioxid Redox Signal, 15:147–151. 2011.

179.

Vendemiale

, Grattagliano

, Altomare

, Turturro

, Guerrieri

. Effect of acetaminophen administration on hepatic glutathione compartmentation and mitochondrial energy metabolism in the rat. Biochem Pharmacol, 52:1147–1154. 1996.

180.

Venkatakrishnan

, Nakayasu

, Almeida

, Miller

. Absence of nitric-oxide synthase in sequentially purified rat liver mitochondria. J Biol Chem, 284:19843–19855. 2009.

181.

Vina

, Sastre

, Anton

, Bruseghini

, Esteras

, Asensi

. Effect of aging on glutathione metabolism. Protection by antioxidants. EXS, 62:136–144. 1992.

182.

Wang

, Masutani

, Oka

, Tanaka

, Yamaguchi-Iwai

, Nakamura

, Yodoi

. Control of mitochondrial outer membrane permeabilization and Bcl-xL levels by thioredoxin 2 in DT40 cells. J Biol Chem, 281:7384–7391. 2006.

183.

Wei

, Jiang

, Matthews

, Colburn

. Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies. Proc Natl Acad Sci USA, 105:19738–19743. 2008.

184.

Weil

, Jacobson

, Coles

, Davies

, Gardner

, Raff

. Constitutive expression of the machinery for programmed cell death. J Cell Biol, 133:1053–1059. 1996.

185.

Wenzel

, Hink

, Oelze

, Schuppan

, Schaeuble

, Schildknecht

, Ho

, Weiner

, Bachschmid

, Munzel

, Daiber

. Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance. J Biol Chem, 282:792–799. 2007.

186.

West

, Hill

, Xuan

, Bhatnagar

. Protein glutathiolation by nitric oxide: An intracellular mechanism regulating redox protein modification. FASEB J, 20:1715–1717. 2006.

187.

Wilkins

, Marquardt

, Lash

, Linseman

. Bcl-2 is a novel interacting partner for the 2-oxoglutarate carrier and a key regulator of mitochondrial glutathione. Free Radic Biol Med, 52:410–419. 2012.

188.

Wonsey

, Zeller

, Dang

. The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation. Proc Natl Acad Sci USA, 99:6649–6654. 2002.

189.

Woo

, Chae

, Hwang

, Yang

, Kang

, Kim

, Rhee

. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science, 300:653–656. 2003.

190.

Woo

, Jeong

, Chang

, Park

, Yang

, Rhee

. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J Biol Chem, 280:3125–3128. 2005.

191.

Woo

, Yim

, Shin

, Kang

, Yu

, Rhee

. Inactivation of peroxiredoxin I by phosphorylation allows localized H₂O₂ accumulation for cell signaling. Cell, 140:517–528. 2010.

192.

Wood-Allum

, Barber

, Kirby

, Heath

, Holden

, Mead

, Higginbottom

, Allen

, Beaujeux

, Alexson

, Ince

, Shaw

. Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen. Brain, 129:1693–1709. 2006.

193.

Wood

, Poole

, Karplus

. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science, 300:650–653. 2003.

194.

Wood

, Schroder

, Robin Harris

, Poole

. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci, 28:32–40. 2003.

195.

Wüllner

, Seyfried

, Groscurth

, Beinroth

, Winter

, Gleichmann

, Heneka

, Löschmann

, Schulz

, Weller

, Klockgether

. Glutathione depletion and neuronal cell death: The role of reactive oxygen intermediates and mitochondrial function. Brain Res, 826:53–62. 1999.

196.

Yin

, Sancheti

, Cadenas

. Silencing of nicotinamide nucleotide transhydrogenase impairs cellular redox homeostasis and energy metabolism in PC12 cells. Biochim Biophys Acta, 1817:401–409. 2012.

197.

Ying

. NAD+/NADH and NADP⁺/NADPH in cellular functions and cell death: Regulation and biological consequences. Antioxid Redox Signal, 10:179–206. 2008.

198.

Zhang

, Lu

, Whiteman

, Chance

, Armstrong

. The mitochondrial permeability transition regulates cytochrome c release for apoptosis during endoplasmic reticulum stress by remodeling the cristae junction. J Biol Chem, 283:3476–3486. 2008.

199.

Zhang

, Go

, Jones

. Mitochondrial thioredoxin-2/peroxiredoxin-3 system functions in parallel with mitochondrial GSH system in protection against oxidative stress. Arch Biochem Biophys, 465:119–126. 2007.

200.

Zhang

, Al-Lamki

, Bai

, Streb

, Miano

, Bradley

, Min

. Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ Res, 94:1483–1491. 2004.

201.

Zhao

, Kalhorn

, Slattery

. Selective mitochondrial glutathione depletion by ethanol enhances acetaminophen toxicity in rat liver. Hepatology, 36:326–335. 2002.

202.

Zhao

, Slattery

. Effects of ethanol dose and ethanol withdrawal on rat liver mitochondrial glutathione: Implication of potentiated acetaminophen toxicity in alcoholics. Drug Metab Dispos., 30:1413–1417. 2002.

203.

Zheng

, Zychlinsky

, Liu

, Ojcius

, Young

. Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol, 112:279–288. 1991.

204.

Zhong

, Putt

, Xu

, Lash

. Hepatic mitochondrial transport of glutathione: Studies in isolated rat liver mitochondria and H4IIE rat hepatoma cells. Arch Biochem Biophys, 474:119–127. 2008.

205.

Zhou

, Kok

, Chun

, Wong

, Wu

, Lin

, Fung

, Kung

, Jin

. Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis. Biochem Biophys Res Commun, 268:921–927. 2000.

206.

Zimmermann

, Loucks

, Schroeder

, Bouchard

, Tyler

, Linseman

. Glutathione binding to the Bcl-2 homology-3 domain groove: A molecular basis for Bcl-2 antioxidant function at mitochondria. J Biol Chem, 282:29296–29304. 2007.

Mitochondrial Thiols in the Regulation of Cell Death Pathways

Abstract

Introduction

The Mitochondrial GSH Pool and Redox Status

Mitochondrial Protein S-Glutathionylation

Mitochondrial Thiols, H2O2, and Domain-Specific Signaling

Mitochondrial GSH in Cell Viability and Function

Conclusions and Perspectives

Footnotes

Acknowledgments

Author Disclosure Statement

Abbreviations Used

References

Mitochondrial Thiols, H₂O₂, and Domain-Specific Signaling